ImmunoCellular Therapeutics (OTCBB: IMUC) announced today that Manish Singh, Ph.D., President and CEO, will be presenting at the Cancer Stem Cells Conference, a leading industry event, on Wednesday, March 24th at 2:00 p.m. eastern time.
At the event, Dr. Singh will present clinical data on ICT-107 and developmental plans for the candidate, preclinical data on ICT-121 and the mechanism of dendritic cell based vaccination, during a session entitled, “Translating Research into Drug Development I.”
Also presenting during the session will be executives from OncoMed, Geron, and Micromet. The conference, hosted by Biorbis, a division of Hanson Wade, will take place at Le Meridien Hotel in Cambridge, MA.
Annual COVID-19 vaccine proves to be a wise investment for personal health and pocketbook